XML 33 R24.htm IDEA: XBRL DOCUMENT v3.21.2
RESTATEMENT OF UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS (Tables) - Revision of Prior Period, Error Correction, Adjustment [Member]
9 Months Ended
Mar. 31, 2021
Balance Sheet [Member]  
RESTATEMENT OF UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS (Tables) [Line Items]  
Schedule of Error Corrections and Prior Period Adjustments [Table Text Block]
   

March 31, 2021

 

Assets

 

(unaudited)

 

(dollars in thousands)

 

As
Previously
Reported

   

Restatement

Adjustments

   

As
Restated

 

Current Assets

                       

Cash and cash equivalents

  $ 9,479     $ -     $ 9,479  

Restricted cash

    1,000       -       1,000  

Investments in securities at fair value

    6,322       -       6,322  

Accounts and other receivables

    2,645       -       2,645  

Prepaid expenses

    430       -       430  

Total Current Assets

    19,876       -       19,876  
                         

Net Property and Equipment

    1,388       -       1,388  
                         

Other Assets

                       

Investments in equity securities at fair value, non-current

    18,635       (1,696 )     16,939  

Investments in available-for-sale debt securities at fair value

    16,470       7,457       23,927  

Other investments

    2,940       -       2,940  

Investments in held-to-maturity debt securities

    1,000       -       1,000  

Equity method investments

    596      
-
      596  

Right of use assets

    56       -       56  

Other assets, non-current

    100       -       100  

Total Other Assets

    39,797       5,761       45,558  

Total Assets

  $ 61,061     $ 5,761     $ 66,822  

Liabilities and Shareholders Equity

                       

Current Liabilities

                       

Accounts payable

  $ 72     $ -     $ 72  

Accrued compensation and related costs

    692       55       747  

Dividends payable

    226       -       226  

Lease liability, short-term

    52       -       52  

Other accrued expenses

    1,221       5       1,226  

Taxes payable

    3,515       (43 )     3,472  

Note payable, current

    -      
-
      -  

Total Current Liabilities

    5,778       17       5,795  
                         

Long-Term Liabilities

                       

Deferred tax liability

    4,681       1,216       5,897  

Lease liability, long-term

    4       -       4  

Total Long-Term Liabilities

    4,685       1,216       5,901  

Total Liabilities

    10,463       1,233       11,696  
                         

Commitments and Contingencies

                       
                         

Shareholders Equity

                       

Common stock (class A) - $0.025 par value; nonvoting; authorized, 28,000,000 shares; issued, 13,866,913 shares at March 31, 2021, and June 30, 2020

    347       -       347  

Common stock (class B) - $0.025 par value; nonvoting; authorized, 4,500,000 shares; no shares issued

    -       -       -  

Convertible common stock (class C) - $0.025 par value; voting; authorized, 3,500,000 shares; issued, 2,068,635 shares at March 31, 2021, and June, 30, 2020

    52       -       52  

Additional paid-in-capital

    15,628       -       15,628  

Treasury stock, class A shares at cost; 883,326 shares and 855,432 shares at March 31, 2021, and June 30, 2020, respectively

    (2,051 )     -       (2,051 )

Accumulated other comprehensive income (loss), net of tax

    1,695       10,145       11,840  

Retained earnings

    34,927       (5,617 )     29,310  

Total Shareholders Equity

    50,598       4,528       55,126  

Total Liabilities and Shareholders Equity

  $ 61,061     $ 5,761     $ 66,822  

 

Statement of Operations [Member]  
RESTATEMENT OF UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS (Tables) [Line Items]  
Schedule of Error Corrections and Prior Period Adjustments [Table Text Block]
   

Nine Months Ended March 31, 2021

   

Three Months Ended March 31, 2021

 

(dollars in thousands, except per share data)

 

As
Previously
Reported

   

Restatement

Adjustments

   

Other Immaterial

Revisions

   

As
Restated

   

As
Previously
Reported

   

Restatement

Adjustments

   

As
Restated

 

Operating Revenues

                                                       

Advisory fees

  $ 14,168     $ -     $ -     $ 14,168     $ 6,304     $ -     $ 6,304  

Administrative services fees

    153       -       -       153       51       -       51  

Other operating revenue

    444       -       (444 )     -       -       -       -  
      14,765       -       (444 )     14,321       6,355       -       6,355  

Operating Expenses

                                                       

Employee compensation and benefits

    5,582       60       -       5,642       1,382       60       1,442  

General and administrative

    4,066       -       -       4,066       1,528       -       1,528  

Advertising

    162       -       -       162       44       -       44  

Depreciation and amortization

    147       -       -       147       49       -       49  
      9,957       60       -       10,017       3,003       60       3,063  

Operating Income (Loss)

    4,808       (60 )     (444 )     4,304       3,352       (60 )     3,292  

Other Income (Loss)

                                                       

Investment income

    37,205       (7,081 )     -       30,124       15,505       (7,081 )     8,424  

Income (loss) from equity method investments

    420       -       -       420       (64 )     -       (64 )

Gain on forgiveness of PPP loan

    -       -       444       444       -       -       -  

Other income

    92       -       -       92       33       -       33  
      37,717       (7,081 )     444       31,080       15,474       (7,081 )     8,393  

Income from Continuing Operations Before Income Taxes

    42,525       (7,141 )     -       35,384       18,826       (7,141 )     11,685  

Provision for Income Taxes

                                                       

Tax expense (benefit)

    9,696       (1,524 )     -       8,172       4,602       (1,524 )     3,078  

Net Income

    32,829       (5,617 )     -       27,212       14,224       (5,617 )     8,607  

Net Income Attributable to U.S. Global Investors, Inc.

  $ 32,829     $ (5,617 )   $ -     $ 27,212     $ 14,224     $ (5,617 )   $ 8,607  
                                                         

Earnings Per Share Attributable to U.S. Global Investors, Inc.

                                                       

Basic Net Income per Share

  $ 2.18     $ (0.37 )   $ -     $ 1.81     $ 0.94     $ (0.37 )   $ 0.57  

Diluted Net Income per Share

  $ 2.18     $ (0.37 )   $ -     $ 1.81     $ 0.94     $ (0.37 )   $ 0.57  
                                                         

Basic weighted average number of common shares outstanding

    15,075,064                       15,075,064       15,061,818               15,061,818  

Diluted weighted average number of common shares outstanding

    15,075,795                       15,075,795       15,062,988               15,062,988  

 

Statement of Comprehensive Income (Loss) [Member]  
RESTATEMENT OF UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS (Tables) [Line Items]  
Schedule of Error Corrections and Prior Period Adjustments [Table Text Block]
   

Nine Months Ended March 31, 2021

   

Three Months Ended March 31, 2021

 

(dollars in thousands)

 

As
Previously
Reported

   

Restatement
Adjustments

   

As
Restated

   

As
Previously
Reported

   

Restatement
Adjustments

   

As
Restated

 

Net Income (Loss) Attributable to U.S. Global Investors, Inc.

  $ 32,829     $ (5,617 )   $ 27,212     $ 14,224     $ (5,617 )   $ 8,607  

Other Comprehensive Income, Net of Tax:

                                               

Unrealized gains on available-for-sale securities arising during period

    1,681       10,581       12,262       1,681       10,581       12,262  

Less: reclassification adjustment for gains included in net income

    -       (436 )     (436 )     -       (436 )     (436 )

Net change from available-for-sale securities, net of tax

    1,681       10,145       11,826       1,681       10,145       11,826  

Foreign currency translation adjustment

    18       -       18       6       -       6  

Other Comprehensive Income

    1,699       10,145       11,844       1,687       10,145       11,832  

Comprehensive Income Attributable to U.S. Global Investors, Inc.

  $ 34,528     $ 4,528     $ 39,056     $ 15,911     $ 4,528     $ 20,439  

 

Statement of Shareholders' Equity [Member]  
RESTATEMENT OF UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS (Tables) [Line Items]  
Schedule of Error Corrections and Prior Period Adjustments [Table Text Block]

Balance at March 31, 2021 (dollars in thousands)

 

As

Previously

Reported

   

Restatement

Adjustments

   

As

Restated

 

Accumulated Other Comprehensive Income (Loss)

  $ 1,695     $ 10,145     $ 11,840  

Retained Earnings

  $ 34,927     $ (5,617 )   $ 29,310  

Total

  $ 50,598     $ 4,528     $ 55,126  

 

Statement of Cash Flows [Member]  
RESTATEMENT OF UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS (Tables) [Line Items]  
Schedule of Error Corrections and Prior Period Adjustments [Table Text Block]
   

Nine Months Ended March 31, 2021

 

(dollars in thousands)

 

As
Previously
Reported

   

Restatement

Adjustments

   

Other Immaterial

Revisions

   

As Restated

 

Cash Flows from Operating Activities:

                               

Net income (loss)

  $ 32,829     $ (5,617 )   $ -     $ 27,212  

Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:

                 

Depreciation and amortization

    147       -       -       147  

Net recognized loss on disposal of fixed assets

    7       -       -       7  

Net recognized gain on securities

    (15,506 )     -       -       (15,506 )

Amortization of premium on debt securities

    -       83       -       83  

Accretion of discount on debt securities

    -       (552 )     -       (552 )

Unrealized investment (gains) losses on securities

    -       7,550       (21,226 )     (13,676 )

Investment basis adjustment

    27       -       -       27  

Gain on disposal of Galileo

    -       -       -       -  

Net (income) loss from equity method investment

    (420 )     -       -       (420 )

Net loss from discontinued operations, net of tax

    -       -       -       -  

Foreign currency transaction loss

    -       -       -       -  

Provision for deferred taxes

    4,234       (1,481 )     -       2,753  

Stock bonuses

    18       -       -       18  

PPP loan forgiveness

    (444 )     -       -       (444 )

Changes in operating assets and liabilities:

                               

Accounts receivable and other receivables

    (1,671 )     -       -       (1,671 )

Prepaid expenses and other assets

    (117 )     -       -       (117 )

Investment securities

    (21,226 )     -       21,226       -  

Accounts payable and accrued expenses

    4,062       17       -       4,079  

Total adjustments

    (30,889 )     5,617       -       (25,272 )

Net cash provided by operating activities

    1,940       -       -       1,940  

Cash Flows from Investing Activities:

                               

Purchase of property and equipment

    (36 )     -       -       (36 )

Purchase of investments in securities at fair value, non-current

    (135 )     (5,853 )     -       (5,988 )

Purchase of other investments

    (665 )     -       -       (665 )

Purchase of held-to-maturity investments

    (1,000 )     -       -       (1,000 )

Purchase of available-for-sale investments

    (15,000 )     5,853       -       (9,147 )

Proceeds from sale of Galileo

    -       -       -       -  

Proceeds on sale of non-current investments

    22,355       -       -       22,355  

Proceeds from maturity of corporate bonds

    658       -       -       658  

Return of capital on investments

    -       -       -       -  

Net cash provided by investing activities

    6,177       -       -       6,177  

Cash Flows from Financing Activities:

                               

Issuance of common stock

    4       -       -       4  

Repurchases of common stock

    (189 )     -       -       (189 )

Dividends paid

    (414 )     -       -       (414 )

Net cash used in financing activities

    (599 )     -       -       (599 )

Net increase in cash, cash equivalents, and restricted cash

    7,518       -       -       7,518  

Beginning cash, cash equivalents, and restricted cash

    2,961       -       -       2,961  

Ending cash, cash equivalents, and restricted cash

  $ 10,479     $ -     $ -     $ 10,479  
                                 

Supplemental Disclosures of Cash Flow Information

                               

Cash paid for income taxes

  $ 1,902                     $ 1,902  

 

   

Nine Months Ended March 31, 2020

 

(dollars in thousands)

 

As
Previously
Reported

   

Other Immaterial

Revisions

   

As Restated

 

Cash Flows from Operating Activities:

                       

Net loss

  $ (6,300 )   $ -     $ (6,300 )

Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:

         

Depreciation and amortization

    152       -       152  

Unrealized investment losses on securities

    -       3,995       3,995  

Investment basis adjustment

    (49 )     -       (49 )

Gain on disposal of Galileo

    (151 )     -       (151 )

Net loss from equity method investment

    146       -       146  

Net loss from discontinued operations, net of tax

    338       -       338  

Foreign currency transaction loss

    228       -       228  

Provision for deferred taxes

    (139 )     -       (139 )

Stock bonuses

    3       -       3  

Changes in operating assets and liabilities:

                       

Accounts receivable and other receivables

    108       -       108  

Prepaid expenses and other assets

    (148 )     -       (148 )

Investment securities

    5,707       (5,707 )     -  

Accounts payable and accrued expenses

    456       -       456  

Total adjustments

    6,651       (1,712 )     4,939  

Net cash provided by (used in) operating activities

    351       (1,712 )     (1,361 )

Cash Flows from Investing Activities:

                       

Purchase of other investments

    (75 )     -       (75 )

Proceeds from sale of Galileo

    746       -       746  

Proceeds on sale of current investments

    -       1,712       1,712  

Return of capital on investments

    10       -       10  

Net cash provided by investing activities

    681       1,712       2,393  

Cash Flows from Financing Activities:

                       

Issuance of common stock

    2       -       2  

Repurchases of common stock

    (74 )     -       (74 )

Dividends paid

    (340 )     -       (340 )

Net cash used in financing activities

    (412 )     -       (412 )

Net increase in cash, cash equivalents, and restricted cash

    620       -       620  

Beginning cash, cash equivalents, and restricted cash

    2,491       -       2,491  

Ending cash, cash equivalents, and restricted cash

  $ 3,111     $ -     $ 3,111